FutureWise Research, a leading provider of strategic market intelligence, has published an in-depth new market analysis ...
RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's ...
PALO ALTO, CALIFORNIA / ACCESS Newswire / December 15, 2025 / Bioz, Inc., the leading AI-powered engine for scientific product insights, proudly announces the deployment of 1,000 Bioz Badges on Multi ...
Trial aims to enroll 12 children at eight sites in EU and USPhase 3 trial in adult patients also planned for 2026 with focus on limb sparing associated with bone non-union (BNU)Novadip aims to become ...
Budget speculation kills growth Responding to the latest growth figures, Julian Jessop, Economics Fellow at the Institute of Economic Affairs said: "The further contraction in the UK economy in ...
Global Atherectomy Devices Market OverviewThe global atherectomy devices market is expected to witness substantial growth, with a projected CAGR of around 8% during the forecast period. Several key ...
Sub-Saharan Africa Pharmaceuticals Market OutlookThe Sub-Saharan Africa (SSA) pharmaceuticals market is poised for strong expansion over the coming years, reflecting the region’s evolving healthcare ...
UPPSALA, SE / ACCESS Newswire / December 15, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based cancer monitoring, today announced that the company ...
Everest Medicines announced on Dec. 11, 2025 that its wholly-owned subsidiary, Everest Medicines (China) Co., Ltd , has entered into two strategic agreements with privately held Hasten ...
FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial FDA has completed their review of the Neurizon NUZ-001 regimen to the HEALEY ALS Platform Trial Master Protocol This marks the official ...
GENEVA, SWITZERLAND / ACCESS Newswire / December 15, 2025 / MindMaze Therapeutics Holding SA (SIX:MMTX) (MindMaze Therapeutics or the Company) announced today the completion of its business ...
Company to host webcast Monday, December 15, 2025 at 8:30 a.m. ETBOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback